- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01250938
Effectiveness of Early Intervention in an Underserved Population (ESI-CO)
2/2-Effects of Parent-Implemented Intervention for Toddlers With Autism Spectrum
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Families of racial/ethnic minority, lower levels of education, and those who live in non-metropolitan areas have been found to experience greater limitations in accessing services for Autism Spectrum Disorder (ASD) (Thomas, Ellis, McLaurin, Daniels, & Morrissey, 2007). Black and Hispanic children have been found to have lower odds of having a documented ASD classification than white children (Mandell, Wiggins, Arnstein Carpenter, Daniels, Durkin et al., 2009) and of those children who do receive an ASD diagnosis, many of them are not diagnosed in early childhood. The age of first ASD diagnosis received has been found to be significantly higher for African American and Latino children compared to white children (Mandell, Listerud, Levy, & Pinto-Martin, 2002). For these reasons, it is important that the effectiveness of intensive early intervention for children with ASD is examined across varying cultural and socioeconomic backgrounds.
This project is directed by Dr. Catherine Lord at the University of Michigan, in collaboration with Dr. Amy Wetherby at Florida State University to test the applicability of a modified caregiver-implemented autism intervention (Modified Early Social Interaction; ESI) to a deliberately recruited low-income, underserved population. UM will recruit 28 children and FSU will recruit 16 children diagnosed with ASD who are between 24 and 42 months of age over a period of 3 years, totaling 44 caregiver-child dyads. This study will utilize a multiple baseline single-subject research design. Dyads will complete 1 month of weekly 1-hour baseline observations followed by three months of the modified ESI intervention. Child and family characteristics predicting response to intervention will be identified and findings will contribute to the development of autism interventions serving families from diverse backgrounds.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Tallahassee, Florida, United States, 32301
- Florida State University
-
-
New York
-
White Plains, New York, United States, 10605
- Weill Cornell Medical College
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- caregiver(s) with less than a 4-year college degree
- family income equal to or below 2x the federal poverty line
- English as the predominantly-spoken language.
- child received diagnosis of autism spectrum disorder before treatment
- child is between 24 and 42 months at the start of treatment
- child has normal hearing and adequate motor control to make simple actions (giving, reaching)
- family agrees to 2-4 weeks of weekly 1-hour observations, 3 months of 2 intervention sessions per week, and 3 months of 1 intervention session per month.
- family agrees to pre-treatment, post-treatment, and follow-up evaluation and videotaping of intervention sessions and weekly video check during the treatment.
Exclusion Criteria:
-Must meet eligibility requirements stated above.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: ESI - Community Outreach
All families receive the same Early Social Intervention - Community Outreach (ESI-CO) treatment for 3 months in addition to 6 months of community resource support.
|
This is an individualized caregiver-implemented intervention (ESI-CO) offered in 2 weekly sessions to teach caregivers how to embed strategies to support social communication skills within everyday routines, activities, and places for 3 months.
Additionally, families receive 6 months (3 months during weekly home sessions and three months upon the completion of weekly home sessions) of resource support to identify local and community autism programs available for continued intervention and services.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Caregiver Transactional Support
Time Frame: Weekly
|
Measures caregiver's development of behavioral strategies to support child's social and communicative behavior.
|
Weekly
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Child Outcome
Time Frame: All measures pre-treatment, post-treatment, and at 3 month follow-up. Some measures weekly and monthly
|
Child measures of autism symptoms, social communication, developmental level, and adaptive behavior.
|
All measures pre-treatment, post-treatment, and at 3 month follow-up. Some measures weekly and monthly
|
Caregiver Outcome
Time Frame: All measures pre-treatment, post-treatment, and at 3 month follow-up. Some measures weekly and monthly
|
Caregiver measures self-reported family functioning, resources, well-being and treatment adherence, fidelity, and satisfaction
|
All measures pre-treatment, post-treatment, and at 3 month follow-up. Some measures weekly and monthly
|
Collaborators and Investigators
Investigators
- Principal Investigator: Catherine Lord, Ph.D., Weill Medical College of Cornell University
- Principal Investigator: Amy Wetherby, Ph.D., Florida State University
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1108011843
- Autism Speaks 5766 (Other Grant/Funding Number: Autism Speaks)
- R01MH078165 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Data are maintained by Florida Statue University, the data coordinating center for this collaborative project. We have shared deidentified study data by depositing it in the NIH National Database for Autism Research (NDAR).
We have a long-standing commitment to making our data available to other investigators. As part of our previous work with NIMH (e.g. NIMH Collaborative RO1 MH089390) and others (e.g. Simons Simplex Collection), our data collection methods and data structures have been designed with NDAR's data-sharing protocol in mind (we collect information necessary to generate the Global Unique Identifier). Our study uses standardized assessments and all data are maintained in a secure database.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism Spectrum Disorders
-
Stanford UniversityCalifornia Department of Developmental ServicesRecruitingAutism Spectrum Disorder | Autistic Disorder | Autism | Autism Spectrum Disorders | Autistic Disorders Spectrum | Autistic Spectrum Disorder | Autistic Spectrum DisordersUnited States
-
Hospital Universitario Dr. Jose E. GonzalezUnknownAutism | Autism SpectrumMexico
-
Emory UniversityNational Institute of Mental Health (NIMH)Terminated
-
University Hospital, MontpellierCaisse Nationale de Solidarité pour l'AutonomieActive, not recruitingAutism Spectrum DisordersFrance
-
Institut National de la Santé Et de la Recherche...Completed
-
Linmarie SikichEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedAutism Spectrum DisordersUnited States
-
National Human Genome Research Institute (NHGRI)CompletedAutism Spectrum DisordersUnited States
-
University of California, San DiegoCompletedAutism Spectrum DisordersUnited States
-
Stanford UniversityNational Institute of Mental Health (NIMH)Completed
-
Syracuse UniversityTexas Woman's UniversityCompleted
Clinical Trials on ESI - Community Outreach
-
Jesse NodoraNational Cancer Institute (NCI)TerminatedCoronary Artery Disease | Heart Failure | Obesity | Diabetes Mellitus, Type 2 | Cancer | Chronic Kidney Diseases | Sickle Cell Disease | COPDUnited States
-
University of ChicagoStand Up To CancerRecruitingCancer | Malignant Neoplasm | MalignancyUnited States
-
Rutgers, The State University of New JerseyNational Center for Advancing Translational Sciences (NCATS)CompletedNew Jersey Healthcare Essential Worker Outreach and Education Study - Testing Overlooked OccupationsCovid19 | Health Behavior | Health Care Seeking BehaviorUnited States
-
Brigham and Women's HospitalEastern Research GroupCompletedHypertension | Diabetes Mellitus | Metabolic Syndrome | Chronic DiseaseUnited States
-
Case Comprehensive Cancer CenterRecruiting
-
NYU Langone HealthCompletedMental HealthUnited States
-
Rigshospitalet, DenmarkLundbeck Foundation; Filadelfia Epilepsy Hospital; Lennart Grams Mindefond, Danish...CompletedSurgery | Refractory Epilepsy | Electroencephalography | Brain ImagingDenmark
-
Emory UniversityNational Institute of Mental Health (NIMH)Terminated
-
The New York Academy of MedicineUnknown
-
The New Model of Care, Hail Health ClusterHealth Holding Company, Saudi Arabia; Hail Health Cluster, Saudi ArabiaRecruitingColorectal Neoplasms | Colorectal CancerSaudi Arabia